The CF-70 instrument (product code: LXG; Regulation Number: 862.2050) receives magazines containi...

FDA Device Recall #Z-1703-2020 — Class II — March 9, 2020

Recall Summary

Recall Number Z-1703-2020
Classification Class II — Moderate risk
Date Initiated March 9, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sysmex America, Inc.
Location Lincolnshire, IL
Product Type Devices
Quantity 93 units.

Product Description

The CF-70 instrument (product code: LXG; Regulation Number: 862.2050) receives magazines containing stained blood smears from SP-50, selects only smears that require analysis, and transports them to the DI-60 for further analysis. After completing the analysis on DI-60 the smears are placed back in magazines.

Reason for Recall

Software mismatch-When the software versions between the SP-50 and CF-70 are not matched, and an error condition occurs requiring the operator to open the cover door of the CF-70 to remove slides or slide magazines from the CF-70, the operation of the CF-70 does not halt.

Distribution Pattern

USA nationwide distribution in the states of AK, AR, AZ, CA, CO, CT, DE, FL, IL, KY, LA, MA, MD, MI, MO, MS, MT, NC, NJ, NM, NY, OH, OK, OR, PA, TN, TZ, UT and WA..

Lot / Code Information

Catalog No. AH699752.

Other Recalls from Sysmex America, Inc.

Recall # Classification Product Date
Z-1136-2026 Class II TS-10/TS-10H Tube Sorter, automatic sorting sys... Dec 15, 2025
Z-1113-2025 Class II Sysmex PS-10 Sample Preparation System with sof... Jan 6, 2025
Z-2687-2020 Class II Sysmex PS-10 Sample Preparation System Catalog... Jul 6, 2020
Z-1717-2020 Class II Sysmex CV-11 Sample Unit, an integrated modular... Jan 21, 2020
Z-2953-2018 Class II Sysmex XN-Series Fluorocell PLT, Catalog #CD994... Jul 27, 2018

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.